Literature DB >> 19439012

The interaction of monocyte chemoattractant protein-1 and tumour necrosis factor-alpha in Mycobacterium tuberculosis-induced HIV-1 replication at sites of active tuberculosis.

H Mayanja-Kizza1, M Wu, H Aung, S Liu, H Luzze, C Hirsch, Z Toossi.   

Abstract

Tuberculosis (TB) is a prominent opportunistic infection in HIV-1-infected subjects and enhances HIV-1 replication. TB is associated with excess monocyte chemoattractant protein (MCP)-1 and tumour necrosis factor (TNF)-alpha activity in situ, both of which are implicated in transcriptional activation of HIV-1. The role of MCP-1 and TNF-alpha in activation of HIV-1 during TB and by Mycobacterium tuberculosis (MTB) in mononuclear cells from HIV-1/TB subjects with pleural TB was examined here. Extremely high levels of MCP-1 (as compared with TNF-alpha) protein and mRNA were found in pleural fluid and pleural fluid mononuclear cells. Levels of MCP-1 mRNA were sustained during in vitro culture of pleural fluid mononuclear cells. Neutralization of MCP-1 (but not TNF-alpha), resulted in inhibition of MTB induced HIV-1 gag/pol mRNA. Neutralization of both MCP-1 and TNF-alpha, however, abrogated the effect of anti-MCP-1 antibody on HIV-1 mRNA. LMP-420, a small molecular transcriptional inhibitor of both TNF-alpha and MCP-1 expression, did not reduce MTB-induced HIV-1 expression. These data imply that MCP-1 activity may be critical to activation of HIV-1 at sites of TB. An interplay of MCP-1 and TNF-alpha is also suggested.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439012     DOI: 10.1111/j.1365-3083.2009.02246.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

2.  Comparison of MGIT and Myco/F lytic liquid-based blood culture systems for recovery of Mycobacterium tuberculosis from pleural fluid.

Authors:  Elizabeth Harausz; John Kafuluma Lusiba; Mary Nsereko; John L Johnson; Zahra Toossi; Sam Ogwang; W Henry Boom; Moses L Joloba
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

3.  Short communication: circulating plasma HIV-1 viral protein R in dual HIV-1/tuberculosis infection.

Authors:  Zahra Toossi; Shigou Liu; Mianda Wu; Harriet Mayanja-Kizza; Christina S Hirsch
Journal:  AIDS Res Hum Retroviruses       Date:  2014-06-10       Impact factor: 2.205

4.  Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, Indirubin-3'-monoxime.

Authors:  Zahra Toossi; Mianda Wu; Christina S Hirsch; Harriet Mayanja-Kizza; Joy Baseke; Htin Aung; David H Canaday; Koh Fujinaga
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-06       Impact factor: 2.205

5.  Distinct cytokine and regulatory T cell profile at pleural sites of dual HIV/tuberculosis infection compared to that in the systemic circulation.

Authors:  Z Toossi; C S Hirsch; M Wu; H Mayanja-Kizza; J Baseke; B Thiel
Journal:  Clin Exp Immunol       Date:  2011-03       Impact factor: 4.330

Review 6.  A systematic review of the epidemiology, immunopathogenesis, diagnosis, and treatment of pleural TB in HIV-infected patients.

Authors:  A Aljohaney; K Amjadi; G G Alvarez
Journal:  Clin Dev Immunol       Date:  2012-03-14

7.  Formal reasoning on qualitative models of coinfection of HIV and Tuberculosis and HAART therapy.

Authors:  Anil Sorathiya; Andrea Bracciali; Pietro Liò
Journal:  BMC Bioinformatics       Date:  2010-01-18       Impact factor: 3.169

8.  Loculations and Associated Risk Factors of Childhood Pleural Tuberculosis.

Authors:  Jun-Li Wang; Ming Zhou; Yan-An Zhang; Mao-Shui Wang
Journal:  Front Pediatr       Date:  2021-12-16       Impact factor: 3.418

9.  Small Animal Model of Post-chemotherapy Tuberculosis Relapse in the Setting of HIV Co-infection.

Authors:  Matthew B Huante; Tais B Saito; Rebecca J Nusbaum; Kubra F Naqvi; Sadhana Chauhan; Robert L Hunter; Jeffrey K Actor; Jai S Rudra; Mark A Endsley; Joshua G Lisinicchia; Benjamin B Gelman; Janice J Endsley
Journal:  Front Cell Infect Microbiol       Date:  2020-04-16       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.